Exploration of nucleos(t)ide analogs cessation in power hepatitis B sufferers with hepatitis B e antigen loss
Background: Nucleos(t)ide analogs (NAs) cessation in power hepatitis B (CHB) sufferers stays a matter of debate in scientific observe. Present pointers suggest that sufferers with hepatitis B e antigen (HBeAg) seroconversion discontinue NAs after comparatively long-term consolidation remedy. Nevertheless, many sufferers fail to attain HBeAg seroconversion after the long-term lack of HBeAg, even when hepatitis B floor antigen (HBsAg) loss happens. It stays unclear whether or not NAs can be discontinued on this subset of sufferers.
Intention: To research the outcomes and elements related to HBeAg-positive CHB sufferers with HBeAg loss (with out hepatitis B e antibody) after cessation of NAs.
Strategies: We studied sufferers who discontinued NAs after attaining HBeAg loss. The Cox proportional hazards mannequin was used to establish predictors for virological relapse after cessation of NAs. The cut-off worth of the consolidation interval was confirmed utilizing receiver working attribute curves; we confirmed the cut-off worth of HBsAg in accordance to a earlier research. The log-rank take a look at was used to match cumulative relapse charges amongst teams. We additionally studied sufferers with CHB who achieved HBeAg seroconversion and in contrast their cumulative relapse charges. Propensity rating matching evaluation (PSM) was used to stability baseline traits between the teams.
Outcomes: We included 83 sufferers with HBeAg loss. The imply age of those sufferers was 32.1 ± 9.5 years, and the bulk was male (67.5%). Thirty-eight sufferers relapsed, and the cumulative relapse price at months 3, 6, 12, 24, 36, 60, 120, and 180 had been 22.9%, 36.1%, 41.0%, 43.5%, 45.0%, 45.0%, 45.0%, and 52.8%, respectively. Twenty-six (68.4%) sufferers relapsed within the first Three mo after NAs cessation, and 35 sufferers (92.1%) relapsed within the first 12 months after NAs cessation. Consolidation interval (≥ 24 mo vs < 24 mo) (HR 0.506, P = 0.043) and HBsAg at cessation (≥ 100 IU/mL vs < 100 IU/mL) (HR 14.869, P = 0.008) had been vital predictors in multivariate Cox regression. Within the PSM cohort, which included 144 sufferers, there have been decrease cumulative relapse charges in sufferers with HBeAg seroconversion (P = 0.036).
Conclusion: HBeAg-positive CHB sufferers with HBeAg loss might be able to discontinue NAs remedy after long-term consolidation, particularly in sufferers with HBsAg at cessation < 100 IU/mL. Cautious monitoring, particularly within the early phases after cessation, might guarantee a positive consequence.

CEACAM4 Antibody |
|||
1-CSB-PA005164ESR2HU | Cusabio |
|
|
Description: A polyclonal antibody against CEACAM4. Recognizes CEACAM4 from Human, Mouse, Rat. This antibody is Unconjugated. Tested in the following application: ELISA, WB, IHC; Recommended dilution: WB:1:1000-1:5000, IHC:1:20-1:200 |
CEACAM4 Antibody |
|||
GWB-MQ043G | GenWay Biotech | 50ug | Ask for price |
CEACAM4 antibody |
|||
MBS5302152-01mL | MyBiosource | 0.1mL | EUR 750 |
CEACAM4 antibody |
|||
MBS5302152-5x01mL | MyBiosource | 5x0.1mL | EUR 3215 |
CEACAM4 Polyclonal Antibody |
|||
27275 | SAB | 100ul | EUR 439 |
CEACAM4 Polyclonal Antibody |
|||
27275-100ul | SAB | 100ul | EUR 302.4 |
CEACAM4 Polyclonal Antibody |
|||
27275-50ul | SAB | 50ul | EUR 224.4 |
CEACAM4 Polyclonal Antibody |
|||
E-AB-90053-120uL | Elabscience Biotech | 120uL | EUR 320 |
Description: Unconjugated |
CEACAM4 Polyclonal Antibody |
|||
E-AB-90053-200uL | Elabscience Biotech | 200uL | EUR 530 |
Description: Unconjugated |
CEACAM4 Polyclonal Antibody |
|||
E-AB-90053-60uL | Elabscience Biotech | 60uL | EUR 200 |
Description: Unconjugated |
CEACAM4 Polyclonal Antibody |
|||
E-AB-90053-each | Elabscience Biotech | each | Ask for price |
Description: Unconjugated |
CEACAM4 polyclonal antibody |
|||
BS74341 | Bioworld Biotech | 50ul | EUR 358 |
Description: 1mg/ml in PBS with 0.02% sodium azide, 50% glycerol, pH7.2 |
CEACAM4 Polyclonal Antibody |
|||
E910055 | EnoGene | 100ul | EUR 225 |
Description: Available in various conjugation types. |
CEACAM4 Polyclonal Antibody |
|||
MBS8566242-01mL | MyBiosource | 0.1mL | EUR 305 |
CEACAM4 Polyclonal Antibody |
|||
MBS8566242-01mLAF405L | MyBiosource | 0.1mL(AF405L) | EUR 565 |
CEACAM4 Polyclonal Antibody |
|||
MBS8566242-01mLAF405S | MyBiosource | 0.1mL(AF405S) | EUR 565 |
CEACAM4 Polyclonal Antibody |
|||
MBS8566242-01mLAF610 | MyBiosource | 0.1mL(AF610) | EUR 565 |
CEACAM4 Polyclonal Antibody |
|||
MBS8566242-01mLAF635 | MyBiosource | 0.1mL(AF635) | EUR 565 |
CEACAM4 Polyclonal Antibody |
|||
MBS9130273-002mL | MyBiosource | 0.02mL | EUR 200 |
CEACAM4 Polyclonal Antibody |
|||
MBS9130273-005mL | MyBiosource | 0.05mL | EUR 255 |
CEACAM4 Polyclonal Antibody |
|||
MBS9130273-01mL | MyBiosource | 0.1mL | EUR 345 |
CEACAM4 Polyclonal Antibody |
|||
MBS9130273-02mL | MyBiosource | 0.2mL | EUR 545 |
CEACAM4 Polyclonal Antibody |
|||
MBS9130273-5x02mL | MyBiosource | 5x0.2mL | EUR 2265 |
CEACAM4 Polyclonal Antibody |
|||
MBS9431151-005mL | MyBiosource | 0.05mL | EUR 300 |
CEACAM4 Polyclonal Antibody |
|||
MBS9431151-01mL | MyBiosource | 0.1mL | EUR 390 |
CEACAM4 Polyclonal Antibody |
|||
MBS9431151-5x01mL | MyBiosource | 5x0.1mL | EUR 1610 |
OACA09101-50UL - CEACAM4 Antibody |
|||
OACA09101-50UL | Aviva Systems Biology | 50ul | EUR 189 |
OACA09102-50UL - CEACAM4 Antibody |
|||
OACA09102-50UL | Aviva Systems Biology | 50ul | EUR 189 |
OACA09101-100UL - CEACAM4 Antibody |
|||
OACA09101-100UL | Aviva Systems Biology | 100ul | EUR 230 |
OACA09102-100UL - CEACAM4 Antibody |
|||
OACA09102-100UL | Aviva Systems Biology | 100ul | EUR 230 |
CEACAM4 antibody - N-terminal region |
|||
MBS3207675-01mL | MyBiosource | 0.1mL | EUR 455 |
CEACAM4 antibody - N-terminal region |
|||
MBS3207675-5x01mL | MyBiosource | 5x0.1mL | EUR 1995 |
CEACAM4 Polyclonal Conjugated Antibody |
|||
C27275 | SAB | 100ul | EUR 476.4 |
CEACAM4 Polyclonal Conjugated Antibody |
|||
MBS9439166-01mLAF350 | MyBiosource | 0.1mL(AF350) | EUR 480 |
CEACAM4 Polyclonal Conjugated Antibody |
|||
MBS9439166-01mLAF405 | MyBiosource | 0.1mL(AF405) | EUR 480 |
CEACAM4 Polyclonal Conjugated Antibody |
|||
MBS9439166-01mLAF488 | MyBiosource | 0.1mL(AF488) | EUR 480 |
CEACAM4 Polyclonal Conjugated Antibody |
|||
MBS9439166-01mLAF555 | MyBiosource | 0.1mL(AF555) | EUR 480 |
CEACAM4 Polyclonal Conjugated Antibody |
|||
MBS9439166-01mLBiotin | MyBiosource | 0.1mL(Biotin) | EUR 480 |
Polyclonal CEACAM4 antibody - N-terminal region |
|||
APR00954G | Leading Biology | 0.05mg | EUR 633.6 |
Description: A polyclonal antibody raised in Rabbit that recognizes and binds to Human CEACAM4 - N-terminal region. This antibody is tested and proven to work in the following applications: |
ARP45182_P050-25UL - CEACAM4 Antibody - N-terminal region |
|||
ARP45182_P050-25UL | Aviva Systems Biology | 25ul | EUR 99 |
ARP45182_P050 - CEACAM4 antibody - N-terminal region (ARP45182_P050) |
|||
ARP45182_P050 | Aviva Systems Biology | 100ul | EUR 389 |
CEACAM4 Rabbit pAb |
|||
A10055 | Abclonal | 50μL | EUR 623.48 |
CEACAM4 Rabbit pAb |
|||
A10055-100ul | Abclonal | 100 ul | EUR 369.6 |
CEACAM4 Rabbit pAb |
|||
A10055-200ul | Abclonal | 200 ul | EUR 550.8 |
CEACAM4 Rabbit pAb |
|||
A10055-20ul | Abclonal | 20 ul | EUR 219.6 |
CEACAM4 Rabbit pAb |
|||
A10055-50ul | Abclonal | 50 ul | EUR 267.6 |
CEACAM4 Rabbit pAb |
|||
E45R17690N | EnoGene | 50 ul | EUR 297.75 |
Human CEACAM4 siRNA |
|||
20-abx911387 | Abbexa |
|
|
CEACAM4 siRNA (Human) |
|||
MBS829290-15nmol | MyBiosource | 15nmol | EUR 405 |
CEACAM4 siRNA (Human) |
|||
MBS829290-30nmol | MyBiosource | 30nmol | EUR 565 |
CEACAM4 siRNA (Human) |
|||
MBS829290-5x30nmol | MyBiosource | 5x30nmol | EUR 2450 |
CEACAM4 (untagged)-Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
|||
SC303075 | Origene Technologies GmbH | 10 µg | Ask for price |
CEACAM4 Blocking Peptide |
|||
33R-3092 | Fitzgerald | 100 ug | EUR 119 |
Description: A synthetic peptide for use as a blocking control in assays to test for specificity of CEACAM4 antibody, catalog no. 70R-7236 |
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
abx135973-01mg | Abbexa | 0.1 mg | EUR 175 |
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
20-abx135973 | Abbexa |
|
|
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
abx322701-100g | Abbexa | 100 µg | EUR 350 |
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
20-abx322701 | Abbexa |
|
|
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
abx322701-50g | Abbexa | 50 µg | EUR 250 |
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
abx321245-100g | Abbexa | 100 µg | EUR 350 |
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
20-abx321245 | Abbexa |
|
|
Carcinoembryonic Antigen Related Cell Adhesion Molecule 4 (CEACAM4) Antibody |
|||
abx321245-50g | Abbexa | 50 µg | EUR 250 |
CEACAM4 (GFP-tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
|||
RG220740 | Origene Technologies GmbH | 10 µg | Ask for price |
Human CEACAM4 ELISA KIT |
|||
ELI-11048h | Lifescience Market | 96 Tests | EUR 988.8 |
CEACAM4 (Myc-DDK-tagged)-Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
|||
RC220740 | Origene Technologies GmbH | 10 µg | Ask for price |
Human CEACAM4 shRNA Plasmid |
|||
20-abx950782 | Abbexa |
|
|
Human CEACAM4 Protein Lysate |
|||
MBS139250-002mg | MyBiosource | 0.02mg | EUR 365 |
Human CEACAM4 Protein Lysate |
|||
MBS139250-5x002mg | MyBiosource | 5x0.02mg | EUR 1410 |
CEACAM4 (NM_001817) Human Recombinant Protein |
|||
E45H34626M5 | EnoGene | 20 ug | EUR 785.42 |
CEACAM4 Recombinant Protein (Human) |
|||
RP051595 | ABM | 100 ug | Ask for price |
CEACAM4 ORF Vector (Human) (pORF) |
|||
ORF017199 | ABM | 1.0 ug DNA | Ask for price |
Human CEACAM4 knockout cell line |
|||
ABC-KH2892 | AcceGen | 1 vial | Ask for price |
Description: Human CEACAM4 knockout cell line is HEK293/HeLa cell line, edited by CRISPR/Cas9 technology. |
Human CEACAM4 knockdown cell line |
|||
ABC-KD2892 | AcceGen | 1 vial | Ask for price |
Description: Human CEACAM4 knockdown cell line is engineered by our optimized transduction of the specific shRNA with lentivirus. Knockdown levels are determined via qRT-PCR. Gentaur offers generation of stable knockdown (RNAi) cell lines expressing shRNAs targeting genes of your interest. |
Human CEACAM4 Protein Lysate 20ug |
|||
IHUCEACAM4PLLY20UG | Innovative research | each | EUR 213 |
Description: Human CEACAM4 Protein Lysate 20ug |
CEACAM4 ELISA Kit (Human) (OKCA00630) |
|||
OKCA00630 | Aviva Systems Biology | 96 Wells | EUR 999.6 |
Description: Description of target: Granulocyte orphan receptor that acts as an trigger efficient phagocytosis of attached particles.;Species reactivity: Human;Application: ;Assay info: Assay Methodology: Quantitative Sandwich ELISA;Sensitivity: 15.6 pg/mL |
CEACAM4 Peptide - N-terminal region |
|||
MBS3232641-01mg | MyBiosource | 0.1mg | EUR 180 |
CEACAM4 Peptide - N-terminal region |
|||
MBS3232641-5x01mg | MyBiosource | 5x0.1mg | EUR 730 |
CEACAM4 (NM_001817) Human Over-expression Lysate |
|||
LS001089 | BosterBio | 100ug | EUR 628 |
Description: Transient overexpression lysate of carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
CEACAM4 (NM_001817) Human Over-expression Lysate |
|||
E45H19648-2 | EnoGene | 20 ug | EUR 395 |
OCOA00621-20UG - CEACAM4 Protein Lysate |
|||
OCOA00621-20UG | Aviva Systems Biology | 20ug | EUR 169 |
CEACAM4 3'UTR GFP Stable Cell Line |
|||
TU054157 | ABM | 1.0 ml | EUR 1672.8 |
CEACAM4 sgRNA CRISPR Lentivector set (Human) |
|||
K0426601 | ABM | 3 x 1.0 ug | EUR 406.8 |
Lenti ORF particles, CEACAM4 (mGFP-tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4), 200ul, >10^7 TU/mL |
|||
RC220740L2V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, CEACAM4 (mGFP-tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4), 200ul, >10^7 TU/mL |
|||
RC220740L4V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, CEACAM4 (Myc-DDK tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4), 200ul, >10^7 TU/mL |
|||
RC220740L1V | Origene Technologies GmbH | 200 µl | Ask for price |
Lenti ORF particles, CEACAM4 (Myc-DDK tagged) - Human carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4), 200ul, >10^7 TU/mL |
|||
RC220740L3V | Origene Technologies GmbH | 200 µl | Ask for price |
CEACAM4 Protein Vector (Human) (pPM-C-HA) |
|||
PV068795 | ABM | 500 ng | Ask for price |
CEACAM4 Protein Vector (Human) (pPB-C-His) |
|||
PV068793 | ABM | 500 ng | Ask for price |
CEACAM4 Protein Vector (Human) (pPB-N-His) |
|||
PV068794 | ABM | 500 ng | Ask for price |
CEACAM4 Protein Vector (Human) (pPM-C-His) |
|||
PV068796 | ABM | 500 ng | Ask for price |
CEACAM4 3'UTR Luciferase Stable Cell Line |
|||
TU004157 | ABM | 1.0 ml | EUR 1672.8 |
CEACAM4 sgRNA CRISPR Lentivector (Human) (Target 1) |
|||
K0426602 | ABM | 1.0 ug DNA | EUR 184.8 |
CEACAM4 sgRNA CRISPR Lentivector (Human) (Target 2) |
|||
K0426603 | ABM | 1.0 ug DNA | EUR 184.8 |
CEACAM4 sgRNA CRISPR Lentivector (Human) (Target 3) |
|||
K0426604 | ABM | 1.0 ug DNA | EUR 184.8 |
Recombinant Human CEACAM4 Protein, His, E.coli-1mg |
|||
QP5812-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human CEACAM4 Protein, His, E.coli-10ug |
|||
QP5812-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human CEACAM4 Protein, His, E.coli-50ug |
|||
QP5812-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Human CEACAM4 Protein, His, Yeast-1mg |
|||
QP5812-ye-1mg | EnQuireBio | 1mg | EUR 2262 |
Recombinant Human CEACAM4 Protein, His, E.coli-100ug |
|||
QP5812-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human CEACAM4 Protein, His, E.coli-200ug |
|||
QP5812-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human CEACAM4 Protein, His, E.coli-500ug |
|||
QP5812-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant Human CEACAM4 Protein, His, Yeast-10ug |
|||
QP5812-ye-10ug | EnQuireBio | 10ug | EUR 283.2 |
Recombinant Human CEACAM4 Protein, His, Yeast-50ug |
|||
QP5812-ye-50ug | EnQuireBio | 50ug | EUR 358.8 |
Recombinant Human CEACAM4 Protein, His, Yeast-100ug |
|||
QP5812-ye-100ug | EnQuireBio | 100ug | EUR 576 |
Recombinant Human CEACAM4 Protein, His, Yeast-200ug |
|||
QP5812-ye-200ug | EnQuireBio | 200ug | EUR 892.8 |
Recombinant Human CEACAM4 Protein, His, Yeast-500ug |
|||
QP5812-ye-500ug | EnQuireBio | 500ug | EUR 1447.2 |
AAP45182-100UG - CEACAM4 Peptide - N-terminal region |
|||
AAP45182-100UG | Aviva Systems Biology | 100ug | EUR 99 |
Recombinant Human CEACAM4 Protein, His (Fc)-Avi-tagged |
|||
CEACAM4-571H | Creative BioMart | 50ug | EUR 2398.4 |
Description: For long term storage, aliquot and store at -20 to -80 centigrade. Avoid repeated freezing and thawing cycles. |
Human Carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
|||
1-CSB-EP005164HU | Cusabio |
|
|
Description: Recombinant Human Carcinoembryonic antigen-related cell adhesion molecule 4(CEACAM4),partial expressed in E.coli |
Human Carcinoembryonic antigen-related cell adhesion molecule 4 (CEACAM4) |
|||
1-CSB-YP005164HU | Cusabio |
|
|
Description: Recombinant Human Carcinoembryonic antigen-related cell adhesion molecule 4(CEACAM4),partial expressed in Yeast |
Ceacam4 (Rat) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
SR511381 | Origene Technologies GmbH | 2 nmol | Ask for price |
CEACAM3 / CEACAM6 Antibody |
|||
abx323361-100g | Abbexa | 100 µg | EUR 250 |
CEACAM3 / CEACAM6 Antibody |
|||
20-abx323361 | Abbexa |
|
|
CEACAM3 / CEACAM6 Antibody |
|||
abx323361-50g | Abbexa | 50 µg | EUR 187.5 |
CEACAM3/CEACAM6 Antibody |
|||
MBS7122421-005mg | MyBiosource | 0.05mg | EUR 150 |
CEACAM3/CEACAM6 Antibody |
|||
MBS7122421-01mg | MyBiosource | 0.1mg | EUR 190 |
CEACAM3/CEACAM6 Antibody |
|||
MBS7122421-5x01mg | MyBiosource | 5x0.1mg | EUR 845 |
CEACAM3/CEACAM6 Antibody |
|||
1-CSB-PA006209 | Cusabio |
|
|
Description: A polyclonal antibody against CEACAM3/CEACAM6. Recognizes CEACAM3/CEACAM6 from Human. This antibody is Unconjugated. Tested in the following application: WB, ELISA;WB:1/500-1/2000.ELISA:1/10000 |
CEACAM4 (Human) - 3 unique 27mer siRNA duplexes - 2 nmol each |
|||
SR319693 | Origene Technologies GmbH | 2 nmol | Ask for price |
CEACAM4 sgRNA CRISPR/Cas9 All-in-One Lentivector set (Human) |
|||
K0426605 | ABM | 3 x 1.0 ug | EUR 451.2 |
Pig Carcinoembryonic antigen related cell adhesion molecule 4(CEACAM4) ELISA kit |
|||
E07C1597-192T | BlueGene | 192 tests | EUR 1524 |
Description: A competitive ELISA for quantitative measurement of Porcine Carcinoembryonic antigen related cell adhesion molecule 4(CEACAM4) in samples from blood, plasma, serum, cell culture supernatant and other biological fluids. This is a high quality ELISA kit developped for optimal performance with samples from the particular species. |
Interim Prostate-Particular Antigen: Predicting for Biochemical Failure Throughout Salvage Radiation Remedy After Prostatectomy
Goal: A subset of sufferers handled with postprostatectomy radiation remedy for biochemical recurrence after surgical procedure fail to reply due to microscopic illness past the irradiated prostate mattress. This work goals to find out whether or not a rising interim prostate-specific antigen (PSA) throughout radiation remedy can predict the probability of subsequent biochemical recurrence.
Strategies and supplies: Between 2010 and 2016, 185 sufferers had salvage radiation remedy to a dose of 68 Gy with out androgen deprivation remedy for a rising PSA degree after radical prostatectomy. Sufferers had their PSA recorded on the primary day of radiation remedy and once more after finishing the 25th fraction (of 34 complete fractions). Biochemical failure after radiation remedy was outlined as a PSA worth ≥0.2 ng/mL inside 2 years after radiation remedy. Each univariate and multivariate Cox regression fashions had been used for statistical evaluation. Elements with a P worth of <.2 in univariate evaluation had been then utilized in a multivariate evaluation.
Outcomes: The two-year freedom from biochemical failure was 60% (95% confidence interval, 53%-67%). When assessing the interim PSA, 143 sufferers (77%) had a drop in interim PSA; of those sufferers, 71% had 2-year biochemical management. Forty-two sufferers (23%) had a secure or rising interim PSA, and solely 24% of those sufferers had 2-year biochemical management. On multivariate evaluation, a drop in PSA throughout radiation remedy (P < .0001) and a constructive surgical margin (P < .0001) had been vital elements for freedom from subsequent biochemical failure, and seminal vesicle invasion was related to biochemical failure at 2 years (P = .019). All sufferers with a rising interim PSA, unfavorable surgical margin, and seminal vesicle invasion in the end had biochemical failure at 2 years.
Conclusions: A PSA rise throughout salvage radiation remedy is prognostic of biochemical failure at 2 years. Elements reminiscent of seminal vesicle invasion and a unfavorable surgical margin additionally predict for poor responders to salvage radiation remedy.
The function of 68 Gallium-prostate-specific membrane antigen positron emission tomography on staging of high-risk localized prostate most cancers: for all high-risk sufferers or wouldn’t it be higher to pick them?
Background: Based on pathologico-scientific options, sufferers identified with localized prostate most cancers (PCa) are stratified into distinct threat teams (low-risk, intermediate-risk or high-risk). Information have demonstrated that 68Gallium-prostate-specific membrane antigen positron emission tomography (68Ga-PSMA PET/CT) is superior to traditional radiological exams (CT or MRI and bone scintigraphy) within the major staging of high-risk localized PCa. Nevertheless, it’s nonetheless unknown if in a inhabitants of high-risk PCa, there would be a subgroup of sufferers with a better chance of figuring out metastatic illness by the 68Ga-PSMA PET/CT.
Supplies and strategies: Information from sufferers with localized PCa who underwent 68GA-PSMA PET/CT for major staging from 4 establishments had been retrospectively collected. We chosen sufferers with at the very least one D’Amico classification threat issue (Worldwide Society of Urological Pathology ≥ IV and/or prostate-specific antigen > 20 ng/ml). To detect an affiliation between extent of illness and variety of threat elements in addition to Worldwide Society of Urological Pathology prostate most cancers grade, contingency tables had been used, and Fisher Precise Take a look at was carried out.
Outcomes: Between 2016 and 2020, 60 sufferers underwent a 68GA-PSMA PET/CT for major staging of high-risk localized PCa. Concerning the variety of threat elements, 37 sufferers (62%) had one threat issue, and 23 (38%) had two threat elements. Within the subgroup of sufferers with metastatic illness (n = 22), these with two threat elements had increased incidence of metastatic illness, and it was statistically vital (p = 0.011).
Conclusion: This retrospective evaluation demonstrated that 68GA-PSMA PET/CT was in a position to establish superior illness in additional than one-third of sufferers with high-risk illness particularly these with two adversarial threat elements.
Hepatitis B Surface Antigen Antibody |
|||
GWB-F21AB1 | GenWay Biotech | 1 mg | Ask for price |
Hepatitis B surface antigen Antibody |
|||
GWB-F44C6A | GenWay Biotech | 0.1 mg | Ask for price |
Hepatitis B surface antigen Antibody |
|||
GWB-1771DC | GenWay Biotech | 0.1 mg | Ask for price |
Hepatitis B surface antigen Antibody |
|||
GWB-18B7D0 | GenWay Biotech | 0.1 mg | Ask for price |
Hepatitis B surface antigen Antibody |
|||
GWB-195209 | GenWay Biotech | 0.5 mg | Ask for price |
Hepatitis B Surface Antigen Antibody (HRP) |
|||
GWB-7F64AF | GenWay Biotech | 0.1 mg | Ask for price |
Hepatitis B surface antigen |
|||
MBS320112-01mg | MyBiosource | 0.1mg | EUR 355 |
Hepatitis B surface antigen |
|||
MBS320112-5x01mg | MyBiosource | 5x0.1mg | EUR 1500 |
Hepatitis B surface antigen |
|||
MBS320113-01mg | MyBiosource | 0.1mg | EUR 355 |
Hepatitis B surface antigen |
|||
MBS320113-5x01mg | MyBiosource | 5x0.1mg | EUR 1500 |
Hepatitis B surface antigen |
|||
MBS320114-01mg | MyBiosource | 0.1mg | EUR 355 |
Hepatitis B surface antigen |
|||
MBS320114-5x01mg | MyBiosource | 5x0.1mg | EUR 1500 |
Hepatitis B surface antigen |
|||
MBS320115-01mg | MyBiosource | 0.1mg | EUR 355 |
Hepatitis B surface antigen |
|||
MBS320115-5x01mg | MyBiosource | 5x0.1mg | EUR 1500 |
Hepatitis B surface antigen |
|||
MBS320116-01mg | MyBiosource | 0.1mg | EUR 355 |
Hepatitis B surface antigen |
|||
MBS320116-5x01mg | MyBiosource | 5x0.1mg | EUR 1500 |
Hepatitis B Surface Antigen |
|||
MBS6507653-01mg | MyBiosource | 0.1mg | EUR 555 |
Hepatitis B Surface Antigen |
|||
MBS6507653-5x01mg | MyBiosource | 5x0.1mg | EUR 2355 |
Hepatitis B - surface antigen |
|||
MBS324120-1mL | MyBiosource | 1mL | EUR 315 |
Hepatitis B - surface antigen |
|||
MBS324120-5x1mL | MyBiosource | 5x1mL | EUR 1320 |
Hepatitis B - surface antigen |
|||
MBS324121-1mL | MyBiosource | 1mL | EUR 325 |
Hepatitis B - surface antigen |
|||
MBS324121-5x1mL | MyBiosource | 5x1mL | EUR 1375 |
Hepatitis B - surface antigen |
|||
MBS324122-1mL | MyBiosource | 1mL | EUR 345 |
Hepatitis B - surface antigen |
|||
MBS324122-5x1mL | MyBiosource | 5x1mL | EUR 1465 |
Hepatitis B surface antigen |
|||
MBS324123-1mL | MyBiosource | 1mL | EUR 395 |
Hepatitis B surface antigen |
|||
MBS324123-5x1mL | MyBiosource | 5x1mL | EUR 1685 |
Hepatitis B - surface antigen |
|||
MBS324124-1mL | MyBiosource | 1mL | EUR 325 |
Hepatitis B - surface antigen |
|||
MBS324124-5x1mL | MyBiosource | 5x1mL | EUR 1375 |
Hepatitis B - surface antigen |
|||
MBS324125-1mL | MyBiosource | 1mL | EUR 325 |
Hepatitis B - surface antigen |
|||
MBS324125-5x1mL | MyBiosource | 5x1mL | EUR 1375 |
Hepatitis B - surface antigen |
|||
MBS324126-1mL | MyBiosource | 1mL | EUR 340 |
Hepatitis B - surface antigen |
|||
MBS324126-5x1mL | MyBiosource | 5x1mL | EUR 1425 |
Hepatitis B - surface antigen |
|||
MBS324127-1mL | MyBiosource | 1mL | EUR 360 |
Hepatitis B - surface antigen |
|||
MBS324127-5x1mL | MyBiosource | 5x1mL | EUR 1520 |
Hepatitis B - surface antigen |
|||
MBS324128-1mL | MyBiosource | 1mL | EUR 340 |
Hepatitis B - surface antigen |
|||
MBS324128-5x1mL | MyBiosource | 5x1mL | EUR 1425 |
Hepatitis B Surface Antigen Antibody (Ad/Ay) |
|||
GWB-406C01 | GenWay Biotech | 1 ml | Ask for price |
Hepatitis B Surface Antigen Antibody (Ad/Ay) |
|||
GWB-B67323 | GenWay Biotech | 0.2 mg | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx240304-100l | Abbexa | 100 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx240304-50l | Abbexa | 50 µl | EUR 350 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx239778-100l | Abbexa | 100 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx239778-100ug | Abbexa | 100 ug | EUR 577.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx239778-50l | Abbexa | 50 µl | EUR 387.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx342052-100l | Abbexa | 100 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx342052-50l | Abbexa | 50 µl | EUR 2575 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx342091-100l | Abbexa | 100 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx342091-50l | Abbexa | 50 µl | EUR 2575 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx376359-96tests | Abbexa | 96 tests | EUR 225 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021777-1mg | Abbexa | 1 mg | EUR 1220.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021777-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021777-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021778-1mg | Abbexa | 1 mg | EUR 1220.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021778-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021778-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021779-1mg | Abbexa | 1 mg | EUR 1220.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021779-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021779-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021780-1mg | Abbexa | 1 mg | EUR 1220.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021780-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021780-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021781-1mg | Abbexa | 1 mg | EUR 1178.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021781-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021781-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021782-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021782-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021782-80l | Abbexa | 80 µl | EUR 787.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021783-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021783-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021783-80l | Abbexa | 80 µl | EUR 787.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021784-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021784-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021784-80l | Abbexa | 80 µl | EUR 787.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021785-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021785-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021785-80l | Abbexa | 80 µl | EUR 787.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021786-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021786-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021786-80l | Abbexa | 80 µl | EUR 725 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021806-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021806-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021806-80l | Abbexa | 80 µl | EUR 687.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021807-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021807-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021807-80l | Abbexa | 80 µl | EUR 687.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021808-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021809-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021809-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021809-80l | Abbexa | 80 µl | EUR 662.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021810-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021810-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021810-80l | Abbexa | 80 µl | EUR 762.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021811-1mg | Abbexa | 1 mg | EUR 777.6 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021811-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021811-80l | Abbexa | 80 µl | EUR 825 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021812-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021812-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021812-80l | Abbexa | 80 µl | EUR 762.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021814-1mg | Abbexa | 1 mg | EUR 1387.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021814-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021814-80l | Abbexa | 80 µl | EUR 375 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021815-1mg | Abbexa | 1 mg | EUR 1387.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021815-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021815-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021816-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021816-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021816-80l | Abbexa | 80 µl | EUR 687.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021817-100ug | Abbexa | 100 ug | EUR 794.4 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021817-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021817-80l | Abbexa | 80 µl | EUR 725 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021818-1mg | Abbexa | 1 mg | EUR 777.6 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021818-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021818-80l | Abbexa | 80 µl | EUR 825 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021819-1mg | Abbexa | 1 mg | EUR 661.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021820-1mg | Abbexa | 1 mg | EUR 661.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021821-1mg | Abbexa | 1 mg | EUR 661.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021821-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021821-80l | Abbexa | 80 µl | EUR 637.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx021823-1mg | Abbexa | 1 mg | EUR 661.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx022999-1mg | Abbexa | 1 mg | EUR 577.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx023004-1mg | Abbexa | 1 mg | EUR 811.2 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx023006-1ml | Abbexa | 1 ml | EUR 777.6 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx023006-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx023006-80l | Abbexa | 80 µl | EUR 1050 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx023007-1ml | Abbexa | 1 ml | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx023007-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx023007-80l | Abbexa | 80 µl | EUR 975 |
Hepatitis B Surface Antigen (HBsAg) Antibody |
|||
abx023848-1mg | Abbexa | 1 mg | EUR 718.8 |
Hepatitis B Virus Surface Antigen Antibody |
|||
20-abx134235 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody |
|||
20-abx134236 | Abbexa |
|
|
Hepatitis B Virus surface antigen Antibody |
|||
GWB-4BAE14 | GenWay Biotech | 1 ml | Ask for price |
Hepatitis A Surface Antigen Antibody |
|||
GWB-8A0702 | GenWay Biotech | 0.2 mg | Ask for price |
Hepatitis A Surface Antigen Antibody |
|||
GWB-DFB8F4 | GenWay Biotech | 0.2 mg | Ask for price |
HEPATITIS B SURFACE ANTIGEN AY |
|||
GWB-F1CE5F | GenWay Biotech | 0.1 mg | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
abx021776-1mg | Abbexa | 1 mg | EUR 1296 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
abx021776-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
abx021776-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
abx021822-1mg | Abbexa | 1 mg | EUR 1296 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
abx023002-1ml | Abbexa | 1 ml | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
abx023002-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
abx023002-80l | Abbexa | 80 µl | EUR 1112.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
abx023005-1ml | Abbexa | 1 ml | EUR 886.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
abx023005-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (HRP) |
|||
abx023005-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen Antibody (AD/AY) (FITC) |
|||
GWB-ABE5A1 | GenWay Biotech | 1 ml | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody Pair |
|||
abx137761-100l | Abbexa | 100 µl | EUR 350 |
Hepatitis B Surface Antigen (HBsAg) Antibody Pair |
|||
abx137761-500l | Abbexa | 500 µl | EUR 950 |
Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
abx023001-1ml | Abbexa | 1 ml | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
abx023001-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
abx023001-80l | Abbexa | 80 µl | EUR 1112.5 |
Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
abx023009-1ml | Abbexa | 1 ml | EUR 844.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
abx023009-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (FITC) |
|||
abx023009-80l | Abbexa | 80 µl | EUR 1175 |
Hepatitis B Surface Antigen Antibody (ready to use) |
|||
GWB-95C198 | GenWay Biotech | 6 ml | Ask for price |
Hepatitis B Virus Surface Antigen Antibody (HRP) |
|||
20-abx134237 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody (HRP) |
|||
20-abx134238 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody (HRP) |
|||
GWB-475DB7 | GenWay Biotech | 0.1 ml | Ask for price |
OASA00809-200UG - HEPATITIS B SURFACE ANTIGEN Antibody |
|||
OASA00809-200UG | Aviva Systems Biology | 0.2mg | EUR 459 |
OASA00814-100UG - HEPATITIS B SURFACE ANTIGEN Antibody |
|||
OASA00814-100UG | Aviva Systems Biology | 0.1mg | EUR 469 |
HBsAg, Hepatitis B Surface Antigen |
|||
MBS397225-1mL | MyBiosource | 1mL | EUR 475 |
HBsAg, Hepatitis B Surface Antigen |
|||
MBS397225-5x1mL | MyBiosource | 5x1mL | EUR 1985 |
Hepatitis B Surface Antigen (HBsAg) |
|||
MBS6507654-1mL | MyBiosource | 1mL | EUR 510 |
Hepatitis B Surface Antigen (HBsAg) |
|||
MBS6507654-5x1mL | MyBiosource | 5x1mL | EUR 2135 |
Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
abx023000-1ml | Abbexa | 1 ml | EUR 718.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
abx023000-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
abx023000-80l | Abbexa | 80 µl | EUR 1050 |
Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
abx023008-1ml | Abbexa | 1 ml | EUR 844.8 |
Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
abx023008-400l | Abbexa | 400 µl | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (Biotin) |
|||
abx023008-80l | Abbexa | 80 µl | EUR 1087.5 |
Hepatitis B Virus Surface Antigen Antibody (FITC) |
|||
20-abx134239 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody (FITC) |
|||
20-abx134240 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody (Biotin) |
|||
20-abx134241 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody (Biotin) |
|||
20-abx134242 | Abbexa |
|
|
Hepatitis B Virus Surface Antigen Antibody (Biotin) |
|||
GWB-A855CE | GenWay Biotech | 0.1 ml | Ask for price |
Hepatitis B Virus Surface Antigen Antibody (Biotin) |
|||
GWB-13CFC6 | GenWay Biotech | 0.1 ml | Ask for price |
Hepatitis B Surface Antigen (HBsAg) Antibody (ad/ay) |
|||
GWB-T00719 | GenWay Biotech | 1 mg | Ask for price |
Hepatitis B,surface Antigen, (HbsAg) Antibody, Concentrate |
|||
PAB361C | Innovex | 0.2ml | EUR 455 |
Hepatitis B Antibody (Virus Surface Antigen) (FITC) |
|||
GWB-8ABE07 | GenWay Biotech | 0.1 ml | Ask for price |
Recombinant Hepatitis B Surface Antigen |
|||
DAG435 | Creative Diagnostics | 100ug | EUR 673.31 |
Description: Recombinant |
Hepatitis B Virus Surface Antigen (HBsAg) Antibody |
|||
abx137498-100tests | Abbexa | 100 tests | EUR 225 |
Hepatitis B Virus Surface Antigen (HBsAg) Antibody |
|||
20-abx137498 | Abbexa |
|
|
Hepatitis B Surface Antigen (HBsAg) (ay) |
|||
MBS319706-1mg | MyBiosource | 1mg | EUR 1090 |
Hepatitis B Surface Antigen (HBsAg) (ay) |
|||
MBS319706-5x1mg | MyBiosource | 5x1mg | EUR 4735 |
Hepatitis B Surface Antigen (HBsAg) Ab |
|||
MBS569782-1mg | MyBiosource | 1mg | EUR 305 |
Hepatitis B Surface Antigen (HBsAg) Ab |
|||
MBS569782-5x1mg | MyBiosource | 5x1mg | EUR 1180 |
Hepatitis B Surface Antigen (HBsAg) Ab |
|||
MBS569783-1mg | MyBiosource | 1mg | EUR 305 |
Hepatitis B Surface Antigen (HBsAg) Ab |
|||
MBS569783-5x1mg | MyBiosource | 5x1mg | EUR 1180 |
Hepatitis B Surface Antigen (HBsAg) Ab |
|||
MBS569784-1mg | MyBiosource | 1mg | EUR 305 |
Hepatitis B Surface Antigen (HBsAg) Ab |
|||
MBS569784-5x1mg | MyBiosource | 5x1mg | EUR 1180 |
Hepatitis B Surface Antigen (HBsAg) Ab |
|||
MBS568132-1mg | MyBiosource | 1mg | EUR 485 |
Hepatitis B Surface Antigen (HBsAg) Ab |
|||
MBS568132-5x1mg | MyBiosource | 5x1mg | EUR 1980 |